Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026)
Kodiak Sciences (KOD) posted Free Cash Flow of -$41.0 million for Q1 2026, down 3.88% on a QoQ basis from -$39.4 million in Q4 2025, and down 39.54% year-over-year from -$67.7 million in Q1 2025.
Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026) Analysis & Trends
Kodiak Sciences' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$41.0 million for Q1 2026.
- Quarterly Free Cash Flow fell 39.54% year-over-year to -$41.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.1 million (down 37.91% YoY) and the FY2025 annual result came in at -$136.5 million, down 16.01% from the prior year.
- Free Cash Flow was -$41.0 million for Q1 2026 at Kodiak Sciences, down from -$39.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$21.3 million in Q3 2024 and bottomed at -$63.4 million in Q2 2022.
- A 5-year average of -$43.2 million and a median of -$39.6 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 69.04% — and 2024, when it jumped 49.48%.
- Kodiak Sciences' Free Cash Flow stood at -$58.2 million in 2022, then fell by 2.65% to -$59.7 million in 2023, then soared by 49.48% to -$30.2 million in 2024, then slumped by 30.64% to -$39.4 million in 2025, then slipped by 3.88% to -$41.0 million in 2026.
- Business Quant data shows KOD's Free Cash Flow at -$41.0 million in Q1 2026, -$39.4 million in Q4 2025, and -$32.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -40.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.95 Mn |
| Mar 31, 2026 | -40.95 Mn |
| Dec 31, 2025 | -39.42 Mn |
| Dec 31, 2025 | -39.42 Mn |
| Sep 30, 2025 | -32.89 Mn |
| Sep 30, 2025 | -32.89 Mn |
| Jun 30, 2025 | -34.86 Mn |
| Jun 30, 2025 | -34.86 Mn |
| Mar 31, 2025 | -29.35 Mn |
| Mar 31, 2025 | -29.35 Mn |
| Dec 31, 2024 | -30.18 Mn |
| Dec 31, 2024 | -30.18 Mn |
| Sep 30, 2024 | -21.33 Mn |
| Sep 30, 2024 | -21.33 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Mar 31, 2024 | -39.62 Mn |
| Mar 31, 2024 | -39.62 Mn |
| Dec 31, 2023 | -59.72 Mn |
| Dec 31, 2023 | -59.72 Mn |